Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company

FDA inspection history in Manati, Puerto Rico, 2019 to 2026

3
Form 483s

Every document, by year

  • Form 483

2019: one Form 483; 2021: one Form 483; 2026: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019–21Two Form 483s, at Manati, Puerto Rico.
  2. 2021The longest 483 on file: 9 observations over 18 pages at Manati, Puerto Rico.
  3. 2026One Form 483, at Manati, Puerto Rico.

Cited most

Across all Bristol-Myers Squibb Holdings Pharma Ltd. Liability observations on file

The complete Bristol-Myers Squibb Holdings Pharma Ltd. Liability file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2026-02-13483 Form 483$99
2021-07-12483 Form 483$99
2019-11-19483 Form 483$99

FEI number 2650089 · most recent document Feb 13, 2026

About Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company

How many FDA Form 483s has Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company received?

FDA Intel has 3 Form 483s on file for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company; the most recent is dated Feb 13, 2026.

When was Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company last inspected by FDA?

The most recent FDA inspection document on file for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company is a Form 483 dated Feb 13, 2026, for the site in Manati, Puerto Rico.

What did FDA cite at Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company?

The regulations cited most in the observations on file for Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company are 21 CFR 211.113 (Control of microbiological contamination), 3 times; 21 CFR 211.22 (Responsibilities of quality control unit), 3 times; 21 CFR 820, 1 time.